Author Contributions: Dr Morrow had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Studyconcept and design: Morrow, Hawley, Katz.
Acquisition of data: Hamilton, Graff, Katz.
Analysis and interpretation of data: Morrow, Jagsi, Alderman, Griggs, Hawley, Katz.
Drafting of the manuscript: Morrow, Hawley, Katz.
Critical revision of the manuscript for important intellectual content: Morrow, Jagsi, Alderman, Griggs, Hawley, Hamilton, Graff, Katz.
Statistical analysis: Hawley, Katz.
Administrative, technical, or material support: Graff, Hamilton, Hawley, Katz.
Study supervision: Hamilton, Graff, Katz.
Financial Disclosures: None reported.
Funding/Support: This work was funded by grants R01 CA109696 and R01 CA088370 from the National Cancer Institute to the University of Michigan. Dr Katz was supported by an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences Research from the National Cancer Institute (K05CA111340). Dr Jagsi is supported by Mentored Research Scholar grant MRSG-09-145-01 from the American Cancer Society. The collection of Los Angeles County cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code §103885. The National Cancer Institute's Surveillance, Epidemiology, and End Results Program under contract N01-PC-35139 was awarded to the University of Southern California. Contract N01-PC-54404 and agreement 1U58DP00807-01 were awarded to the Public Health Institute. The collection of metropolitan Detroit cancer incidence data was supported by the National Cancer Institute's Surveillance, Epidemiology, and End Results Program under contract N01-PC-35145.
Role of the Sponsors: The funding organizations and sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Disclaimer: The ideas and opinions expressed herein are those of the authors. Endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended and should not be inferred.
Additional Contributions: We acknowledge the outstanding work of our project staff: Barbara Salem, MS, MSW, Paul Abrahamse, MS, and Ashley Gay, BA (University of Michigan); Ain Boone, BA, Cathey Boyer, MSA, and Deborah Wilson, BA (Wayne State University); and Alma Acosta, Mary Lo, MS, Norma Caldera, Marlene Caldera, and Maria Isabel Gaeta (University of Southern California), as well as the editorial assistance of Shan-san Wu, BA (Memorial Sloan-Kettering Cancer Center). All of these individuals received compensation for their assistance. We also acknowledge the breast cancer patients who responded to our survey. We thank the American College of Surgeons Commission on Cancer (David Winchester, MD, and Connie Bura) and the National Cancer Institute Outcomes Branch (Neeraj Arora, PhD, and Steven Clauser, PhD) for their support.